{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T08:54:45Z","timestamp":1781513685946,"version":"3.54.1"},"reference-count":113,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.cca.2026.121009","type":"journal-article","created":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T15:38:39Z","timestamp":1776440319000},"page":"121009","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Circulating metabolic and inflammatory biomarkers in MINOCA: pathophysiologic mechanisms and clinical implications"],"prefix":"10.1016","volume":"589","author":[{"given":"Fuad A.","family":"Abdu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hengji","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peiyuan","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cca.2026.121009_bb0005","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/s41569-023-00927-6","article-title":"Sex-specific and ethnicity-specific differences in MINOCA","volume":"21","author":"La","year":"2024","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.cca.2026.121009_bb0010","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehab730","article-title":"Early cardiac magnetic resonance leads to diagnose the etiology of myocardial infarction with non-obstructive coronary arteries","volume":"43","author":"Tsuda","year":"2022","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.cca.2026.121009_bb0015","doi-asserted-by":"crossref","first-page":"e891","DOI":"10.1161\/CIR.0000000000000670","article-title":"Contemporary diagnosis and management of patients with myocardial infarction in the absence of obstructive coronary artery disease: a scientific statement from the American Heart Association","volume":"139","author":"Tamis-Holland","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.cca.2026.121009_bb0020","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1161\/CIRCULATIONAHA.117.027666","article-title":"Myocardial infarction with nonobstructive coronary arteries (MINOCA): the past, present, and future management","volume":"135","author":"Pasupathy","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.cca.2026.121009_bb0025","doi-asserted-by":"crossref","unstructured":"R.A. Byrne, X. Rossello, J.J. Coughlan, E. Barbato, C. Berry, A. Chieffo, M.J. Claeys, G.A. Dan, M.R. Dweck, M. Galbraith, M. Gilard, L. Hinterbuchner, E.A. Jankowska, P. J\u00fcni, T. Kimura, V. Kunadian, M. Leosdottir, R. Lorusso, R.F.E. Pedretti, A.G. Rigopoulos, M. Rubini Gimenez, H. Thiele, P. Vranckx, S. Wassmann, N.K. Wenger, B. Ibanez, 2023 ESC guidelines for the management of acute coronary syndromes, Eur. Heart J. 44 (2023) 3720\u20133826. Doi;https:\/\/doi.org\/10.1093\/eurheartj\/ehad191.","DOI":"10.1093\/eurheartj\/ehad191"},{"key":"10.1016\/j.cca.2026.121009_bb0030","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1093\/eurheartj\/ehz403","article-title":"Myocardial infarction with non-obstructive coronary arteries as compared with myocardial infarction and obstructive coronary disease: outcomes in a Medicare population","volume":"41","author":"Dreyer","year":"2020","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.cca.2026.121009_bb0035","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1161\/CIRCULATIONAHA.116.026336","article-title":"Medical therapy for secondary prevention and long-term outcome in patients with myocardial infarction with nonobstructive coronary artery disease","volume":"135","author":"Lindahl","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.cca.2026.121009_bb0040","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.124.036802","article-title":"Clinical characteristics and outcome of patients with myocardial infarction with nonobstructive coronary arteries in Japan: insights from the miyagi acute myocardial infarction registry study","volume":"14","author":"Hao","year":"2025","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.cca.2026.121009_bb0045","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.118.009174","article-title":"Presentation, clinical profile, and prognosis of young patients with myocardial infarction with nonobstructive coronary arteries (MINOCA): results from the VIRGO study","volume":"7","author":"Safdar","year":"2018","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.cca.2026.121009_bb0050","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1136\/heartjnl-2020-318269","article-title":"MINOCA: a heterogenous group of conditions associated with myocardial damage","volume":"107","author":"Singh","year":"2021","journal-title":"Heart"},{"key":"10.1016\/j.cca.2026.121009_bb0055","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCOUTCOMES.121.007880","article-title":"Survival in patients with suspected myocardial infarction with nonobstructive coronary arteries: a comprehensive systematic review and Meta-analysis from the MINOCA global collaboration","volume":"14","author":"Pasupathy","year":"2021","journal-title":"Circ. Cardiovasc. Qual. Outcomes"},{"key":"10.1016\/j.cca.2026.121009_bb0060","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1161\/CIRCULATIONAHA.114.011201","article-title":"Systematic review of patients presenting with suspected myocardial infarction and nonobstructive coronary arteries","volume":"131","author":"Pasupathy","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.cca.2026.121009_bb0065","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.124.035329","article-title":"Sex differences and clinical outcomes in patients with myocardial infarction with nonobstructive coronary arteries: a Meta-analysis","volume":"13","author":"Ang","year":"2024","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.cca.2026.121009_bb0070","doi-asserted-by":"crossref","DOI":"10.1093\/eurjpc\/zwaf495","article-title":"Sex influence on in-hospital and long-term prognosis of myocardial infarction with non-obstructive coronary artery disease. A systematic review and meta-analysis","author":"Herrera Flores","year":"2025","journal-title":"Eur. J. Prev. Cardiol."},{"key":"10.1016\/j.cca.2026.121009_bb0075","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.pcad.2023.10.006","article-title":"Characteristics of patients with recurrent acute myocardial infarction after MINOCA","volume":"81","author":"Ciliberti","year":"2023","journal-title":"Prog. Cardiovasc. Dis."},{"key":"10.1016\/j.cca.2026.121009_bb0080","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1093\/eurheartj\/ehu469","article-title":"Acute myocardial infarction with no obstructive coronary atherosclerosis: mechanisms and management","volume":"36","author":"Niccoli","year":"2015","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.cca.2026.121009_bb0085","doi-asserted-by":"crossref","unstructured":"B. Ibanez, S. James, S. Agewall, M.J. Antunes, C. Bucciarelli-Ducci, H. Bueno, A.L.P. Caforio, F. Crea, J.A. Goudevenos, S. Halvorsen, G. Hindricks, A. Kastrati, M.J. Lenzen, E. Prescott, M. Roffi, M. Valgimigli, C. Varenhorst, P. Vranckx, P. Widimsk\u00fd, 2017 ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation, Eur. Heart J. 39 (2018) 119\u2013177. Doi;https:\/\/doi.org\/10.1093\/eurheartj\/ehx393.","DOI":"10.5603\/KP.2018.0041"},{"key":"10.1016\/j.cca.2026.121009_bb0090","doi-asserted-by":"crossref","first-page":"504","DOI":"10.23736\/S2724-5683.23.06414-1","article-title":"#FullPhysiology: a systematic step-by-step guide to implement intracoronary physiology in daily practice","volume":"71","author":"Scarsini","year":"2023","journal-title":"Minerva Cardiol. Angiol."},{"key":"10.1016\/j.cca.2026.121009_bb0095","doi-asserted-by":"crossref","DOI":"10.1186\/s13045-014-0080-6","article-title":"Immunosuppressive\/anti-inflammatory cytokines directly and indirectly inhibit endothelial dysfunction--a novel mechanism for maintaining vascular function","volume":"7","author":"Shao","year":"2014","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.cca.2026.121009_bb0100","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1007\/s00395-008-0733-0","article-title":"The role of inflammatory cytokines in endothelial dysfunction","volume":"103","author":"Zhang","year":"2008","journal-title":"Basic Res. Cardiol."},{"key":"10.1016\/j.cca.2026.121009_bb0105","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/j.yjmcc.2011.08.018","article-title":"Influence of obesity and metabolic dysfunction on the endothelial control in the coronary circulation","volume":"52","author":"Belin de Chantemele","year":"2012","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.cca.2026.121009_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2021.154766","article-title":"Insulin resistance, cardiovascular stiffening and cardiovascular disease","volume":"119","author":"Hill","year":"2021","journal-title":"Metabolism"},{"key":"10.1016\/j.cca.2026.121009_bb0115","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.pharmthera.2005.10.008","article-title":"Vascular endothelial dysfunction in diabetic cardiomyopathy: pathogenesis and potential treatment targets","volume":"111","author":"Farhangkhoee","year":"2006","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.cca.2026.121009_bb0120","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1093\/eurheartj\/eht513","article-title":"Coronary microvascular dysfunction: an update","volume":"35","author":"Crea","year":"2014","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.cca.2026.121009_bb0125","doi-asserted-by":"crossref","DOI":"10.31083\/j.fbl2703105","article-title":"Oxidative stress-induced endothelial dysfunction in cardiovascular diseases","volume":"27","author":"Shaito","year":"2022","journal-title":"Front. Biosci. (Landmark Ed)"},{"key":"10.1016\/j.cca.2026.121009_bb0130","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1007\/s11239-023-02862-2","article-title":"Molecular mechanisms of endothelial dysfunction in coronary microcirculation dysfunction","volume":"56","author":"Zhang","year":"2023","journal-title":"J. Thromb. Thrombolysis"},{"key":"10.1016\/j.cca.2026.121009_bb0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.numecd.2025.104104","article-title":"Metabolic syndrome severity score and long-term cardiovascular outcomes in patients with myocardial infarction with nonobstructive coronary arteries","volume":"35","author":"Gao","year":"2025","journal-title":"Nutr. Metab. Cardiovasc. Dis."},{"key":"10.1016\/j.cca.2026.121009_bb0140","doi-asserted-by":"crossref","DOI":"10.1186\/s12933-021-01384-6","article-title":"Impact of admission hyperglycemia on short and long-term prognosis in acute myocardial infarction: MINOCA versus MIOCA","volume":"20","author":"Paolisso","year":"2021","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.cca.2026.121009_bb0145","doi-asserted-by":"crossref","DOI":"10.1186\/s12933-021-01222-9","article-title":"Hyperglycemia, inflammatory response and infarct size in obstructive acute myocardial infarction and MINOCA","volume":"20","author":"Paolisso","year":"2021","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.cca.2026.121009_bb0150","doi-asserted-by":"crossref","DOI":"10.1186\/s12933-023-01742-6","article-title":"Association of stress hyperglycemia ratio and poor long-term prognosis in patients with myocardial infarction with non-obstructive coronary arteries","volume":"22","author":"Abdu","year":"2023","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.cca.2026.121009_bb0155","doi-asserted-by":"crossref","first-page":"3184","DOI":"10.1016\/j.numecd.2021.07.027","article-title":"Impact of triglyceride-glucose index on long-term cardiovascular outcomes in patients with myocardial infarction with nonobstructive coronary arteries","volume":"31","author":"Gao","year":"2021","journal-title":"Nutr. Metab. Cardiovasc. Dis."},{"key":"10.1016\/j.cca.2026.121009_bb0160","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1161\/CIRCULATIONAHA.105.563213","article-title":"Reciprocal relationships between insulin resistance and endothelial dysfunction: molecular and pathophysiological mechanisms","volume":"113","author":"Kim","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.cca.2026.121009_bb0165","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1161\/CIRCRESAHA.116.309326","article-title":"Roles of vascular oxidative stress and nitric oxide in the pathogenesis of atherosclerosis","volume":"120","author":"F\u00f6rstermann","year":"2017","journal-title":"Circ. Res."},{"key":"10.1016\/j.cca.2026.121009_bb0170","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/nri3793","article-title":"Cholesterol, inflammation and innate immunity","volume":"15","author":"Tall","year":"2015","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.cca.2026.121009_bb0175","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1093\/eurheartj\/ehz962","article-title":"Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel","volume":"41","author":"Bor\u00e9n","year":"2020","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.cca.2026.121009_bb0180","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.ejim.2024.03.024","article-title":"The correlation of atherogenic index of plasma with non-obstructive CAD and unfavorable prognosis among patients diagnosed with MINOCA","volume":"125","author":"Abdu","year":"2024","journal-title":"Eur. J. Intern. Med."},{"key":"10.1016\/j.cca.2026.121009_bb0185","article-title":"Role of lipoprotein ratios and remnant cholesterol in patients with myocardial infarction with non-obstructive coronary arteries (MINOCA)","volume":"11","author":"Sucato","year":"2024","journal-title":"J. Cardiovasc. Dev. Dis."},{"key":"10.1016\/j.cca.2026.121009_bb0190","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.121.024366","article-title":"Remnant cholesterol predicts risk of cardiovascular events in patients with myocardial infarction with nonobstructive coronary arteries","volume":"11","author":"Gao","year":"2022","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.cca.2026.121009_bb0195","doi-asserted-by":"crossref","first-page":"960","DOI":"10.3390\/jcm12030960","article-title":"Absence of high lipoprotein(A) levels is an independent predictor of acute myocardial infarction without coronary lesions","volume":"12","author":"Kallmeyer","year":"2023","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.cca.2026.121009_bb0200","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.708216","article-title":"Predictive value of free triiodothyronine to free thyroxine ratio in euthyroid patients with myocardial infarction with nonobstructive coronary arteries","volume":"12","author":"Gao","year":"2021","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"10.1016\/j.cca.2026.121009_bb0205","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1080\/07853890.2021.1931428","article-title":"Impact of low triiodothyronine syndrome on long-term outcomes in patients with myocardial infarction with nonobstructive coronary arteries","volume":"53","author":"Gao","year":"2021","journal-title":"Ann. Med."},{"key":"10.1016\/j.cca.2026.121009_bb0210","doi-asserted-by":"crossref","first-page":"92","DOI":"10.15605\/jafes.034.01.14","article-title":"Hyperthyroidism presenting as ST elevation myocardial infarction with normal coronaries - a case report","volume":"34","author":"Krishnan","year":"2019","journal-title":"J. ASEAN Fed. Endocr. Soc."},{"key":"10.1016\/j.cca.2026.121009_bb0215","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/ehjcr\/ytaa191","article-title":"A case report of myocardial infarction with non-obstructive coronary artery disease: graves\u2019 disease-induced coronary artery vasospasm","volume":"4","author":"Klomp","year":"2020","journal-title":"Eur. Heart J. Case Rep."},{"key":"10.1016\/j.cca.2026.121009_bb0220","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/852954","article-title":"Review of hyperuricemia as new marker for metabolic syndrome","volume":"2014","author":"Billiet","year":"2014","journal-title":"ISRN Rheumatol."},{"key":"10.1016\/j.cca.2026.121009_bb0225","article-title":"Hyperuricemia and its related diseases: mechanisms and advances in therapy","volume":"9","author":"Du","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.cca.2026.121009_bb0230","article-title":"Hyperuricemia predicts adverse outcomes after myocardial infarction with non-obstructive coronary arteries","volume":"8","author":"Mohammed","year":"2021","journal-title":"Front. Med. (Lausanne)"},{"key":"10.1016\/j.cca.2026.121009_bb0235","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.28985","article-title":"Associations of serum uric acid levels with macrovascular and renal microvascular dysfunction among individuals from sub-Saharan Africa","volume":"4","author":"Hayfron-Benjamin","year":"2021","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.cca.2026.121009_bb0240","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1097\/HJH.0000000000001212","article-title":"Serum uric acid and the relationship with subclinical organ damage in adults","volume":"35","author":"Lambert","year":"2017","journal-title":"J. Hypertens."},{"key":"10.1016\/j.cca.2026.121009_bb0245","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1161\/HYPERTENSIONAHA.116.08436","article-title":"Uric acid is associated with inflammation, coronary microvascular dysfunction, and adverse outcomes in postmenopausal women","volume":"69","author":"Prasad","year":"2017","journal-title":"Hypertension"},{"key":"10.1016\/j.cca.2026.121009_bb0250","volume":"17","author":"Wang","year":"2025","journal-title":"Diabetol. Metab. Syndr."},{"key":"10.1016\/j.cca.2026.121009_bb0255","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1161\/CIRCRESAHA.124.325488","article-title":"Renal-cardiac crosstalk in the pathogenesis and progression of heart failure","volume":"136","author":"Noels","year":"2025","journal-title":"Circ. Res."},{"key":"10.1016\/j.cca.2026.121009_bb0260","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1161\/CIRCRESAHA.123.321752","article-title":"Endothelial cell dysfunction and increased cardiovascular risk in patients with chronic kidney disease","volume":"132","author":"Baaten","year":"2023","journal-title":"Circ. Res."},{"key":"10.1016\/j.cca.2026.121009_bb0265","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1681\/ASN.2006030204","article-title":"Cross-talk between the kidney and the cardiovascular system","volume":"17","author":"Amann","year":"2006","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.cca.2026.121009_bb0270","doi-asserted-by":"crossref","first-page":"2557","DOI":"10.1007\/s11255-021-02794-x","article-title":"The outcome of patients with myocardial infarction with non-obstructive coronary arteries (MINOCA) and impaired kidney function: a 3-year observational study","volume":"53","author":"Zalewska-Adamiec","year":"2021","journal-title":"Int. Urol. Nephrol."},{"key":"10.1016\/j.cca.2026.121009_bb0275","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.hjc.2023.08.001","article-title":"The impact of renal function on the three-year outcomes in patients with myocardial infarction with nonobstructive coronary arteries","volume":"77","author":"Kim","year":"2024","journal-title":"Hellenic J. Cardiol."},{"key":"10.1016\/j.cca.2026.121009_bb0280","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1007\/s40265-020-01290-3","article-title":"ACE inhibitor benefit to kidney and cardiovascular outcomes for patients with non-dialysis chronic kidney disease stages 3-5: a network Meta-analysis of randomised clinical trials","volume":"80","author":"Zhang","year":"2020","journal-title":"Drugs"},{"key":"10.1016\/j.cca.2026.121009_bb0285","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1161\/CIR.0000000000000183","article-title":"Pharmacotherapy in chronic kidney disease patients presenting with acute coronary syndrome: a scientific statement from the American Heart Association","volume":"131","author":"Washam","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.cca.2026.121009_bb0290","doi-asserted-by":"crossref","first-page":"986","DOI":"10.7150\/ijms.70833","article-title":"Association between initial serum total bilirubin and clinical outcome in myocardial infarction with non-obstructive coronary arteries","volume":"19","author":"Yin","year":"2022","journal-title":"Int. J. Med. Sci."},{"key":"10.1016\/j.cca.2026.121009_bb0295","doi-asserted-by":"crossref","DOI":"10.3390\/diseases12050103","article-title":"Bile acids and bilirubin role in oxidative stress and inflammation in cardiovascular diseases","volume":"12","author":"Punzo","year":"2024","journal-title":"Diseases"},{"key":"10.1016\/j.cca.2026.121009_bb0300","doi-asserted-by":"crossref","first-page":"F123","DOI":"10.1152\/ajprenal.00039.2014","article-title":"Circulating bilirubin and defense against kidney disease and cardiovascular mortality: mechanisms contributing to protection in clinical investigations","volume":"307","author":"Boon","year":"2014","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"10.1016\/j.cca.2026.121009_bb0305","doi-asserted-by":"crossref","first-page":"H429","DOI":"10.1152\/ajpheart.00417.2017","article-title":"Bilirubin acts as a multipotent guardian of cardiovascular integrity: more than just a radical idea","volume":"315","author":"Bulmer","year":"2018","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.cca.2026.121009_bb0310","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijcard.2024.132665","article-title":"The association between fibrinogen-to-albumin ratio and adverse prognosis in patients with myocardial infarction with non-obstructive coronary arteries","volume":"418","author":"Fang","year":"2025","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.cca.2026.121009_bb0315","doi-asserted-by":"crossref","first-page":"2625","DOI":"10.1016\/j.jacc.2018.09.042","article-title":"Coronary microvascular disease pathogenic mechanisms and therapeutic options: JACC state-of-the-art review","volume":"72","author":"Taqueti","year":"2018","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.cca.2026.121009_bb0320","first-page":"54","article-title":"Editor\u2019s choice- pathophysiology, diagnosis and management of MINOCA: an update","volume":"8","author":"Scalone","year":"2019","journal-title":"Eur. Heart J. Acute Cardiovasc. Care"},{"key":"10.1016\/j.cca.2026.121009_bb0325","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","article-title":"Antiinflammatory therapy with canakinumab for atherosclerotic disease","volume":"377","author":"Ridker","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cca.2026.121009_bb0330","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines9070781","article-title":"Inflammatory mechanisms contributing to endothelial dysfunction","volume":"9","author":"Theofilis","year":"2021","journal-title":"Biomedicines"},{"key":"10.1016\/j.cca.2026.121009_bb0335","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1161\/CIRCRESAHA.115.306656","article-title":"From C-reactive protein to interleukin-6 to interleukin-1: moving upstream to identify novel targets for atheroprotection","volume":"118","author":"Ridker","year":"2016","journal-title":"Circ. Res."},{"key":"10.1016\/j.cca.2026.121009_bb0340","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aal2658","article-title":"Detecting human coronary inflammation by imaging perivascular fat","volume":"9","author":"Antonopoulos","year":"2017","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.cca.2026.121009_bb0345","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s11897-017-0337-9","article-title":"Inflammation - cause or consequence of heart failure or both?","volume":"14","author":"Van Linthout","year":"2017","journal-title":"Curr. Heart Fail. Rep."},{"key":"10.1016\/j.cca.2026.121009_bb0350","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1373\/clinchem.2018.301085","article-title":"Increased inflammatory activity in patients 3 months after myocardial infarction with nonobstructive coronary arteries","volume":"65","author":"Hjort","year":"2019","journal-title":"Clin. Chem."},{"key":"10.1016\/j.cca.2026.121009_bb0355","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1038\/s41569-021-00552-1","article-title":"Interplay between inflammation and thrombosis in cardiovascular pathology","volume":"18","author":"Stark","year":"2021","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.cca.2026.121009_bb0360","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1161\/CIRCULATIONAHA.112.093245","article-title":"The assessment of endothelial function: from research into clinical practice","volume":"126","author":"Flammer","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.cca.2026.121009_bb0365","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1172\/JCI92035","article-title":"Inflammatory mechanisms linking obesity and metabolic disease","volume":"127","author":"Saltiel","year":"2017","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.cca.2026.121009_bb0370","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/5642406","article-title":"Combination of white blood cell count to mean platelet volume ratio and neutrophil-to-platelet ratio predicts long-term adverse events in patients with MINOCA","volume":"2022","author":"Mohammed","year":"2022","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.cca.2026.121009_bb0375","doi-asserted-by":"crossref","first-page":"8281","DOI":"10.2147\/JIR.S482596","article-title":"Prognostic value of systemic inflammation response index and N-terminal pro-B-type natriuretic peptide in patients with myocardial infarction with nonobstructive coronary arteries- a retrospective study","volume":"17","author":"Hou","year":"2024","journal-title":"J. Inflamm. Res."},{"key":"10.1016\/j.cca.2026.121009_bb0380","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1002\/clc.23651","article-title":"Clinical and prognostic implications of C-reactive protein levels in myocardial infarction with nonobstructive coronary arteries","volume":"44","author":"Eggers","year":"2021","journal-title":"Clin. Cardiol."},{"key":"10.1016\/j.cca.2026.121009_bb0385","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2024.1367919","article-title":"Immune-inflammatory biomarkers for the occurrence of MACE in patients with myocardial infarction with non-obstructive coronary arteries","volume":"11","author":"Zhou","year":"2024","journal-title":"Front. Cardiovasc. Med."},{"key":"10.1016\/j.cca.2026.121009_bb0390","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.013235","article-title":"Coronary inflammation by computed tomography pericoronary fat attenuation in MINOCA and Tako-Tsubo syndrome","volume":"8","author":"Gaibazzi","year":"2019","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.cca.2026.121009_bb0395","doi-asserted-by":"crossref","DOI":"10.3390\/jpm13121669","article-title":"Pro-inflammatory biomarkers and progression of atherosclerosis in patients with myocardial infarction with non-obstructive coronary artery disease: 1-year follow-up","volume":"13","author":"Ryabov","year":"2023","journal-title":"J. Pers. Med."},{"key":"10.1016\/j.cca.2026.121009_bb0400","article-title":"Oxidative stress markers are lower in MINOCA than in MI-CAD, despite comparable inflammatory status","volume":"14","author":"Ko\u00e7","year":"2025","journal-title":"Antioxidants (Basel)"},{"key":"10.1016\/j.cca.2026.121009_bb0405","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1373\/clinchem.2005.061408","article-title":"Biomarkers of oxidative damage in human disease","volume":"52","author":"Dalle-Donne","year":"2006","journal-title":"Clin. Chem."},{"key":"10.1016\/j.cca.2026.121009_bb0410","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/360438","article-title":"Lipid peroxidation: production, metabolism, and signaling mechanisms of malondialdehyde and 4-hydroxy-2-nonenal","author":"Ayala","year":"2014","journal-title":"Oxidative Med. Cell. Longev."},{"key":"10.1016\/j.cca.2026.121009_bb0415","doi-asserted-by":"crossref","first-page":"5944","DOI":"10.1021\/cr200084z","article-title":"Free radical lipid peroxidation: mechanisms and analysis","volume":"111","author":"Yin","year":"2011","journal-title":"Chem. Rev."},{"key":"10.1016\/j.cca.2026.121009_bb0420","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1038\/s41573-021-00233-1","article-title":"Targeting oxidative stress in disease: promise and limitations of antioxidant therapy","volume":"20","author":"Forman","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.cca.2026.121009_bb0425","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241814143","article-title":"Helicobacter pylori and pro-inflammatory protein biomarkers in myocardial infarction with and without obstructive coronary artery disease","volume":"24","author":"W\u00e4rme","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cca.2026.121009_bb0430","doi-asserted-by":"crossref","DOI":"10.3390\/jcm10081786","article-title":"Clinical value and time course of pericoronary fat inflammation in patients with angiographically nonobstructive coronaries: a preliminary report","volume":"10","author":"Pergola","year":"2021","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.cca.2026.121009_bb0435","article-title":"Impact of persistence to secondary preventive medication on prognosis for patients with myocardial infarction with and without obstructive coronary arteries","volume":"20","author":"Nordenskj\u00f6ld","year":"2025","journal-title":"PLoS One"},{"key":"10.1016\/j.cca.2026.121009_bb0440","doi-asserted-by":"crossref","DOI":"10.1093\/ehjopen\/oeac077","article-title":"Prognostic impact of secondary prevention medical therapy following myocardial infarction with non-obstructive coronary arteries: a Bayesian and frequentist meta-analysis","volume":"2","author":"Samaras","year":"2022","journal-title":"Eur. Heart J. Open"},{"key":"10.1016\/j.cca.2026.121009_bb0445","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijcard.2022.08.034","article-title":"Impact of secondary prevention medical therapies on outcomes of patients suffering from myocardial infarction with Nonobstructive coronary artery disease (MINOCA): a meta-analysis","volume":"368","author":"De Filippo","year":"2022","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.cca.2026.121009_bb0450","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2019.01606","article-title":"Secondary prevention medical therapy and outcomes in patients with myocardial infarction with non-obstructive coronary artery disease","volume":"10","author":"Paolisso","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.cca.2026.121009_bb0455","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1016\/j.jacc.2009.01.041","article-title":"Tight glycemic control reduces heart inflammation and remodeling during acute myocardial infarction in hyperglycemic patients","volume":"53","author":"Marfella","year":"2009","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.cca.2026.121009_bb0460","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.ijcard.2022.06.027","article-title":"Differential cardiovascular and renal benefits of SGLT2 inhibitors and GLP1 receptor agonists in patients with type 2 diabetes mellitus","volume":"364","author":"Kim","year":"2022","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.cca.2026.121009_bb0465","article-title":"Sodium-glucose cotransporter protein-2 (SGLT-2) inhibitors and glucagon-like peptide-1 (GLP-1) receptor agonists for type 2 diabetes: systematic review and network meta-analysis of randomised controlled trials","volume":"376","year":"2022","journal-title":"BMJ"},{"key":"10.1016\/j.cca.2026.121009_bb0470","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/5584_2020_494","article-title":"GLP-1 receptor agonists and SGLT2 inhibitors for the treatment of type 2 diabetes: new insights and opportunities for cardiovascular protection","volume":"1307","author":"Bertoccini","year":"2021","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.cca.2026.121009_bb0475","doi-asserted-by":"crossref","first-page":"909","DOI":"10.2337\/dc21-1113","article-title":"Primary prevention of cardiovascular and heart failure events with SGLT2 inhibitors, GLP-1 receptor agonists, and their combination in Type 2 diabetes","volume":"45","author":"Wright","year":"2022","journal-title":"Diabetes Care"},{"key":"10.1016\/j.cca.2026.121009_bb0480","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1016\/j.jacc.2018.02.045","article-title":"Thyroid hormones and cardiovascular function and diseases","volume":"71","author":"Razvi","year":"2018","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.cca.2026.121009_bb0485","doi-asserted-by":"crossref","first-page":"103","DOI":"10.2174\/1573403X15666191008111238","article-title":"The role of thyroid diseases and their medications in cardiovascular disorders: a review of the literature","volume":"16","author":"Omidi","year":"2020","journal-title":"Curr. Cardiol. Rev."},{"key":"10.1016\/j.cca.2026.121009_bb0490","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1111\/hdi.12313","article-title":"Febuxostat improves endothelial function in hemodialysis patients with hyperuricemia: a randomized controlled study","volume":"19","author":"Tsuruta","year":"2015","journal-title":"Hemodial. Int."},{"key":"10.1016\/j.cca.2026.121009_bb0495","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1159\/000471893","article-title":"Effect of febuxostat on the endothelial dysfunction in hemodialysis patients: a randomized, placebo-controlled, double-blinded study","volume":"45","author":"Alshahawey","year":"2017","journal-title":"Am. J. Nephrol."},{"key":"10.1016\/j.cca.2026.121009_bb0500","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s00296-013-2857-2","article-title":"As compared to allopurinol, urate-lowering therapy with febuxostat has superior effects on oxidative stress and pulse wave velocity in patients with severe chronic tophaceous gout","volume":"34","author":"Tausche","year":"2014","journal-title":"Rheumatol. Int."},{"key":"10.1016\/j.cca.2026.121009_bb0505","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/nrd3444","article-title":"Anti-inflammatory therapeutics for the treatment of atherosclerosis","volume":"10","author":"Charo","year":"2011","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.cca.2026.121009_bb0510","doi-asserted-by":"crossref","DOI":"10.15420\/ecr.2020.51","article-title":"Anti-inflammatory treatment and cardiovascular outcomes: results of clinical trials","volume":"16","author":"Lorenzatti","year":"2021","journal-title":"Eur. Cardiol."},{"key":"10.1016\/j.cca.2026.121009_bb0515","doi-asserted-by":"crossref","DOI":"10.1007\/s11883-014-0435-z","article-title":"Inflammation and cardiovascular disease: from pathogenesis to therapeutic target","volume":"16","author":"Golia","year":"2014","journal-title":"Curr. Atheroscler. Rep."},{"key":"10.1016\/j.cca.2026.121009_bb0520","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1016\/S0140-6736(21)00520-1","article-title":"IL-6 inhibition with ziltivekimab in patients at high atherosclerotic risk (RESCUE): a double-blind, randomised, placebo-controlled, phase 2 trial","volume":"397","author":"Ridker","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.cca.2026.121009_bb0525","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1136\/annrheumdis-2014-206624","article-title":"The effects of tumour necrosis factor inhibitors, methotrexate, non-steroidal anti-inflammatory drugs and corticosteroids on cardiovascular events in rheumatoid arthritis, psoriasis and psoriatic arthritis: a systematic review and meta-analysis","volume":"74","author":"Roubille","year":"2015","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.cca.2026.121009_bb0530","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1111\/j.1523-1755.2005.00145.x","article-title":"Combination therapy with ACE inhibitors and angiotensin II receptor blockers to halt progression of chronic renal disease: pathophysiology and indications","volume":"67","author":"Wolf","year":"2005","journal-title":"Kidney Int."},{"key":"10.1016\/j.cca.2026.121009_bb0535","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s10741-014-9467-2","article-title":"Mineralocorticoid receptor antagonists as diuretics: can congestive heart failure learn from liver failure?","volume":"20","author":"Masoumi","year":"2015","journal-title":"Heart Fail. Rev."},{"key":"10.1016\/j.cca.2026.121009_bb0540","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2020.107701","article-title":"Mineralocorticoid receptor antagonists in patients with chronic kidney disease","volume":"219","author":"Cosimato","year":"2021","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.cca.2026.121009_bb0545","doi-asserted-by":"crossref","unstructured":"F.L.J. Visseren, F. Mach, Y.M. Smulders, D. Carballo, K.C. Koskinas, M. B\u00e4ck, A. Benetos, A. Biffi, J.M. Boavida, D. Capodanno, B. Cosyns, C. Crawford, C.H. Davos, I. Desormais, E. Di Angelantonio, O.H. Franco, S. Halvorsen, F.D.R. Hobbs, M. Hollander, E.A. Jankowska, M. Michal, S. Sacco, N. Sattar, L. Tokgozoglu, S. Tonstad, K.P. Tsioufis, I. van Dis, I.C. van Gelder, C. Wanner, B. Williams, 2021 ESC guidelines on cardiovascular disease prevention in clinical practice, Eur. Heart J. 42 (2021) 3227-3337. Doi;https:\/\/doi.org\/10.1093\/eurheartj\/ehab484.","DOI":"10.1093\/eurheartj\/ehab484"},{"key":"10.1016\/j.cca.2026.121009_bb0550","doi-asserted-by":"crossref","DOI":"10.1016\/j.cpcardiol.2025.103021","article-title":"Non-invasive imaging assessment in angina with non-obstructive coronary arteries (ANOCA)","volume":"50","author":"Bergamaschi","year":"2025","journal-title":"Curr. Probl. Cardiol."},{"key":"10.1016\/j.cca.2026.121009_bb0555","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.jcmg.2023.05.016","article-title":"Prognostic role of early cardiac magnetic resonance in myocardial infarction with nonobstructive coronary arteries","volume":"17","author":"Bergamaschi","year":"2024","journal-title":"JACC Cardiovasc. Imaging"},{"key":"10.1016\/j.cca.2026.121009_bb0560","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1016\/j.jcmg.2018.12.023","article-title":"Prognostic role of CMR and conventional risk factors in myocardial infarction with nonobstructed coronary arteries","volume":"12","author":"Dastidar","year":"2019","journal-title":"JACC Cardiovasc. Imaging"},{"key":"10.1016\/j.cca.2026.121009_bb0565","doi-asserted-by":"crossref","DOI":"10.1186\/s12968-021-00773-w","article-title":"Role of cardiovascular magnetic resonance in the prognosis of patients with myocardial infarction with non-obstructive coronary arteries","volume":"23","author":"Vicente-Ibarra","year":"2021","journal-title":"J. Cardiovasc. Magn. Reson."}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898126001919?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898126001919?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T08:17:46Z","timestamp":1781511466000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898126001919"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":113,"alternative-id":["S0009898126001919"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2026.121009","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Circulating metabolic and inflammatory biomarkers in MINOCA: pathophysiologic mechanisms and clinical implications","name":"articletitle","label":"Article Title"},{"value":"Clinica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cca.2026.121009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"121009"}}